Company Analysis

BioCardia, Inc. (BCDA)

Nasdaq: BCDA · Biological Products, (No Diagnostic Substances) · Sunnyvale, CA · filing with the SEC since 1996
Grade4.1
◀ Past 2.1● Present 4.6▶ Future 4.9
4 est.

Who runs BioCardia, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Altman Peter
President and CEO. First filing Oct 2016, latest Oct 20, 2026, 101 filings in all.
Officers reporting now
3
of 9 people with a filing in the last fifteen months
Directors reporting now
6
25 people on the record since 2008
Officerssales are open-market, Oct 20, 2025 to Oct 20, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Altman PeterPresident and CEOOct 2016Oct 20, 2026none
Gillis Edward MSenior Vice President, DevicesNov 2020Jul 7, 2026none
Mcclung DavidChief Financial OfficerOct 2016Jul 7, 2026none
Directorssales are open-market, Oct 20, 2025 to Oct 20, 2026
NameRoleFirst filingLatest filingSales, 12 months
Allen Jim L.directorFeb 2020Jul 7, 2026none
Blank Andrew ScottdirectorFeb 2020Jul 7, 2026none
Facteau BilldirectorOct 2023Jul 7, 2026none
Moyes Jay MdirectorOct 2016Jul 7, 2026none
Slosman MarvindirectorDec 2025Jul 7, 2026none
Stertzer Simon HdirectorOct 2016Jul 7, 2026none
Earlier names on the record20, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton BCDA · research, not advice